Telemedicine platforms

The company shape

US telemedicine is a $30 billion to $45 billion category depending on how the boundary is drawn (direct-to-consumer virtual care, employer virtual primary care, specialty telehealth, remote patient monitoring). Category structure fragmented rapidly after 2020. Direct-to-consumer platforms (Teladoc, Amwell, MDLive, Doctor on Demand, Sesame, Talkspace, BetterHelp, Ro, Hims & Hers, Nurx, Wisp) hold the largest brand recognition segment. Employer-contracted virtual primary care (Included Health, Crossover Health, One Medical, Firefly Health) serves large-employer populations. Specialty telehealth platforms (Ophelia for opioid use disorder, Cerebral for mental health, Klarity for allergy, Talkiatry for psychiatry, Brave for eating disorders, Alma and Grow Therapy as therapist networks) cover specific clinical categories.

Revenue bands. Solo clinician telehealth practice (single-state license, cash-pay or single-carrier network): $80K to $350K annually. Small multi-clinician telehealth group (2 to 8 providers, 3 to 10 state licenses): $500K to $3.5M. Regional or specialty-focused platform (10 to 40 providers, 15 to 50 state licenses): $4M to $30M. National consumer platform: $50M to $2B+.

Business model shapes. The cash-pay direct-to-consumer platform charges $79 to $175 per visit or $99 to $299 monthly membership, targets acute and elective concerns (weight loss, mental health, sexual health, dermatology, hair loss, sleep). The insurance-billed telehealth platform contracts with commercial carriers and Medicare Advantage plans at $65 to $140 per visit. The employer-contracted virtual primary care operates as a PMPM (per-member per-month) contract at $12 to $65 per employee per month, covering unlimited or capped visits. The specialty telehealth platform serves specific clinical categories at pricing tailored to segment (opioid use disorder $250 to $500 per month, mental health $99 to $200 per session, chronic condition management on a PMPM basis).

Regulatory environment is complex and evolving. State medical licensure requires providers to hold a license in the state where the patient is physically located during the visit. Interstate Medical Licensure Compact (IMLC) accelerates multi-state licensing for physicians but does not remove the requirement. DEA regulations for controlled substances (the Ryan Haight Act plus post-COVID temporary waivers, subsequent DEA rulemaking in 2023 to 2025 on telehealth controlled substance prescribing) are actively changing. HIPAA discipline for telehealth requires specific technology (encrypted video, secure messaging, BAAs with all vendors). Marketing claims and outcome messaging require compliance review.

Owner economics vary widely. A solo NP telehealth practice at $300K nets $150K to $210K to the clinician-owner. A small group at $2M nets $400K to $700K. Platform-scale unit economics are venture-driven and often unprofitable at scale during growth phases.

The buyer

Telehealth buyers cluster into five segments. The acute care convenience patient (specific concern like UTI, sinusitis, prescription refill, wants a visit within 60 minutes). The specialty condition patient (mental health, weight loss, dermatology, sexual health, sleep, fertility, ADHD, opioid use disorder, wants access to specialty care without months-long wait). The chronic condition patient (diabetes, hypertension, thyroid, autoimmune, wants ongoing management from a clinician who knows them). The convenience-driven primary care patient (uses telehealth for care their PCP cannot fit in, or has no PCP relationship). The employer-covered patient (employer benefit covers virtual primary care, mental health, or specialty programs; the patient uses because it is available and covered).

Acute care patients Google specific symptoms and want the fastest path to prescription. They compare telehealth platforms on visit fee, prescription availability, wait time, and app experience. Direct-to-consumer platforms with strong on-demand availability and one-app-per-condition brand positioning (Nurx for birth control, Wisp for UTI, Ro for weight loss) win this segment on specific conditions.

Specialty condition patients are the fastest-growing segment because access to specialists (psychiatry, dermatology, endocrinology, allergy) through traditional insurance is broken in most metros with 3 to 12 month waits. Telehealth platforms with real specialty depth (Talkiatry for psychiatry, Klarity for allergy, Cerebral or Brightside for mental health, Hers for hair loss, Nurx or Wisp for women's health) capture this segment at premium cash pricing or insurance-covered rates.

Chronic condition patients want continuity with a clinician who knows them across visits. Platforms with a "your care team" model (same clinician or small team over time) retain this segment. Platforms with a random-clinician-per-visit model lose it.

Convenience-driven primary care patients are the DPC-adjacent segment. They use telehealth as substitute primary care because traditional PCP relationships are difficult to maintain. Employer-contracted virtual primary care serves this segment at scale.

Employer-covered patients discover through their employer's benefits portal, HR communications, or the platform's mobile app if pre-installed. Sales motion is B2B account development (benefits directors, TPAs, HR benefits consultants). Marketing to the patient happens through the employer's channels.

Decision drivers across segments: clinician credentials and state licensure clarity, wait time and appointment availability, prescription availability by condition, insurance and cash-pay clarity, app experience, HIPAA and privacy discipline, and reviews with condition-specific detail.

HIPAA and privacy discipline is heightened for telehealth. Marketing content, patient testimonials, in-app messaging, and communication practices require careful review. Consumer privacy expectations for telehealth are meaningfully higher than for in-person care because patients share detailed PHI through devices they associate with personal digital life.

Discovery landscape

First-touch attribution for a specialty-focused telehealth platform: Google organic 30 to 45 percent (research-heavy category), Google Ads 15 to 25 percent (competitive keywords with high LTV justify spend), Instagram and TikTok 10 to 20 percent (largest social contribution in healthcare outside nutrition and weight loss), referral 8 to 15 percent, App Store search 5 to 12 percent, podcast and influencer 4 to 10 percent, Reddit and Facebook groups 3 to 8 percent.

Of the 13 Ranking Surfaces, seven move revenue for telehealth. SEO leads because virtual care research volume is enormous. ASO applies for consumer platforms with member apps. E-E-A-T for medical trust signals across state boundaries. AEO for condition and process queries. GEO extends AEO. Social (Instagram, TikTok, YouTube) drives real inbound. CWV for app-quality web experience.

LSO is meaningfully less relevant for telehealth than for any in-person healthcare category because the map pack is not the primary discovery surface. Some hybrid or geographic-specialty telehealth practices do care about LSO for the metros they serve, but pure D2C national telehealth focuses budget on SEO, paid, and social.

App Store Optimization (ASO) is a first-order concern for platforms with mobile apps. Apple App Store and Google Play rankings for category-specific queries ("mental health app," "weight loss app," "birth control app," "telehealth app") drive significant install volume. ASO includes keyword optimization in app metadata, review generation, screenshot and feature graphic testing, and category ranking work.

Instagram and TikTok drive substantial inbound for consumer telehealth. Platforms with clinician-fronted educational content, honest condition explainers, patient stories with proper consent, and FTC-compliant outcome messaging build followings that convert to sign-ups at reasonable cost-per-acquisition.

Reddit and Facebook communities exchange platform recommendations continuously across mental health, weight loss, ADHD, opioid use disorder, sexual health, and dermatology categories. Platforms that engage authentically (education, honest responses, community sponsorship where appropriate) receive word-of-mouth referrals.

Employer benefits distribution channels (benefits consultants, TPAs, direct sales to benefits directors) are the primary discovery path for employer-contracted virtual care. B2B sales motion, not consumer marketing.

Six surfaces do not move volume meaningfully at typical platform scale. LSO reduced weight for pure D2C. VxSO, VSO at low volume for most platforms (higher for content-forward mental health platforms). KGO applies for named clinician-founders with media presence. GLOBO. Web3. AAO produces measurable answer-engine citation traffic for condition and cost queries; llms.txt v2 is important.

What breaks most often

Seven failure modes recur.

State licensure coverage unclear. Prospective patients want to know if the platform can see them in their state. Platforms that publish a clear state coverage map, list available states by service, and communicate expansion timelines convert visitors better than platforms that leave licensure ambiguous until the intake form.

Pricing hidden. Cash-pay telehealth patients want to see the visit fee or membership cost before starting the intake flow. Platforms that hide pricing behind an eligibility check drop off inquiries at 60 to 80 percent while platforms with clear pricing convert at meaningfully higher rates.

Clinician credentials thin or generic. Platforms with "our clinicians are board-certified" positioning lose to platforms that publish individual clinician bios with real credentials, state licenses, specialties, and photos. Named clinicians build trust in a virtual context where the patient never physically meets the provider.

Overreaching outcome claims. FTC scrutiny of telehealth marketing claims is active, particularly in weight loss, hair loss, mental health, and other elective categories. Claims like "guaranteed results" or "cure" invite enforcement. Realistic outcome ranges with clear caveats satisfy compliance and build trust.

DEA compliance blind spots. Platforms prescribing controlled substances (ADHD stimulants, buprenorphine for opioid use disorder, testosterone) operate in an evolving regulatory environment. Cerebral's 2022 pause on stimulant prescribing after federal scrutiny is the reference case. Platforms with rigorous prescribing protocols, honest patient screening, and clear compliance posture retain both DEA registration and payer contracts.

Continuity of care gap. Many telehealth platforms rotate clinicians per visit. Patients with chronic conditions want continuity. Platforms with "your care team" models or clinician-continuity commitments retain chronic condition patients meaningfully longer than random-assignment models.

HIPAA and privacy gaps in marketing and app data handling. The 2023 to 2025 FTC and HHS enforcement wave on telehealth pixel tracking (Meta Pixel, Google Analytics) that transmits PHI to advertisers has produced substantial settlements. Platforms that continue running consumer tracking pixels on pages with PHI exposure face enforcement action. The fix is technical review of every tracking pixel, use of HIPAA-compliant analytics setups, and disciplined data governance.

The Ranking Surfaces Playbook applied

Tier one: revenue this quarter

SEO. Per-condition and per-service grid. Pages for the platform's clinical categories with dedicated content on each (depression, anxiety, ADHD, weight loss, hair loss, dermatology, sexual health, sleep, opioid use disorder, thyroid, PCOS, etc.). Per-state landing pages for the states the platform serves. Cost transparency pages. Clinician bio pages. Organization plus MedicalBusiness plus MedicalWebPage schema. FAQPage schema.

E-E-A-T. Clinician bios with real credentials, state licenses, board certifications, and specialties. Clinical advisory board disclosed. Medical directors named. HIPAA compliance posture surfaced (BAAs, encryption, privacy program). Prescribing protocols summarized honestly for each medication category. FTC-compliant outcome messaging with clear disclaimers.

ASO. If the platform has an app, ASO is a first-order channel. Keyword optimization, screenshot testing, feature graphic testing, review generation flow via in-app prompts, category ranking work. Apple App Store and Google Play both.

Tier two: compounds

AEO. Direct-answer guides on 30 to 60 condition, cost, treatment, and process queries per clinical category. TL;DR opener, FAQPage schema, honest expectations. Guides bylined by clinicians with credentials shown.

GEO. Organization plus MedicalBusiness schema. sameAs to state medical boards, DEA registration, clinical advisor LinkedIn profiles. llms.txt v2 in place because condition queries land AI-answered at increasing rates.

CWV. LCP under 2s. App-quality web experience.

Tier three: social and community scaling

Instagram and TikTok. Clinician-fronted educational content at 3 to 5 pieces per week. Honest, FTC-compliant. Bio and profile link to sign-up flow.

Reddit and Facebook. Authentic engagement with condition-specific communities. Educational content, honest answers, no cold marketing.

Podcast and email. Guest appearances on condition-adjacent podcasts. Email newsletter with 1 to 4 monthly touches per active user segment.

Tier four: less impact

LSO. Reduced weight for pure D2C. Some LSO for hybrid or geographic-focused platforms.

VxSO, VSO. Low volume. Higher for content-forward mental health platforms.

KGO. Applies for named clinician-founders. GLOBO, Web3 not a fit.

How Playbook priority shifts by platform size

Solo telehealth clinician $80K to $350K: SEO plus tight site with pricing, state coverage, clinician bio, HIPAA posture, review generation. Small group $500K to $3.5M: full SEO grid, per-clinician bios, one social channel with clinician content, AEO on top 15 queries. Regional platform $4M to $30M: full Playbook subset, per-condition and per-state content, ASO if app, social scaling, employer sales for benefits contracts. National consumer platform: brand SEO, ASO, national state licensure operations, employer partnership sales, national account benefits contracts. Compliance review at every step across all sizes given the active regulatory environment.

First 30 / 60 / 90 days

Days 1 to 30

Attribution baseline. Cost per sign-up by channel, sign-up-to-first-visit conversion, first-visit-to-retained-member conversion, retention at month 3 and month 6, and revenue by clinical category and state. State licensure coverage published clearly. Pricing published for each service. Clinician bios with real credentials, state licenses, and photos. HIPAA compliance posture surfaced. FTC-compliant outcome messaging reviewed by counsel. Tracking pixel audit for PHI exposure (fix Meta Pixel, Google Analytics, and any other third-party trackers on pages that transmit PHI). Review generation flow live. Weekly reporting on sign-ups, conversion, retention curve, revenue by clinical category and state.

Days 31 to 60

Site restructure. First 15 to 25 per-condition and per-service pages built with clinician bylines. Per-state coverage pages for expansion states. Cost transparency and insurance clarity across all services. HIPAA-compliant patient story process with legal review. CWV in green. Google Ads restructured into condition-specific campaigns with tight negatives. ASO baseline audit if platform has app (keyword performance, review velocity, screenshot conversion). First 10 AEO guides on the highest-intent condition and cost queries per clinical category.

Days 61 to 90

Social, ASO, and B2B activation. Instagram and TikTok cadence live at 3 to 5 clinician-fronted pieces per week. Authentic Reddit and Facebook engagement. ASO iterations shipped (keyword updates, screenshot tests, review generation flow in-app). Employer benefits outreach for platforms with virtual primary care or specialty programs (15 to 30 target employers or TPAs). Podcast guesting outreach. Twenty AEO guides live cumulative. Rank tracking on condition-and-service and cost queries. First organic ranking gains and ASO category ranking movement between day 60 and day 90. Realistic year-one outcomes: 50 to 150 percent sign-up volume lift depending on channel maturity, retention at month 6 up 5 to 12 points as clinician continuity and comprehensive care differentiate, and employer benefits pipeline established for platforms pursuing that channel.

Measurement stack across the 90-day window

HIPAA-compliant analytics (server-side GA4 or dedicated healthcare analytics tools) with events for sign_up, first_visit_book, first_visit_complete, subscription_renew. CallRail with unique numbers per channel. Practice management and EMR (Elation, Charm, DrChrono, athenaClinicals, custom platform stack) with contact source, service, state, and retention status tagged. Weekly dashboard covering sign-ups by channel, conversion funnel by stage, retention by clinical category, revenue by service and state, review count, and app rating movement. Cost caps: paid media at 8 to 20 percent of trailing revenue (higher than in-person healthcare because national competition is intense). SEO and content at 3 to 6 percent. Practice management, review, ASO, and compliance software at $1,000 to $10,000+ per month depending on scale.